Cocuus, a Spanish technology startup that develops industrial solutions for the production of mimetic food analogues of plant- and cell-based animal protein using 2D/3D laser printing, bioprinting, and robotics, has raised €2.5 million in its Pre Series A funding round to scale its 3D bioprinting technology for the production of alternative proteins.
After Cocuus completed Eatable Adventures’ acceleration program, one of the top global accelerators for food tech startups, the company’s Pre Series A funding round was backed by Cargill Ventures, the investment arm of the multinational meat company, Cargill, Big Idea Ventures, Eatable Adventures, and Tech Transfer UPV – to accelerate Cocuus’s process for producing plant and cell-based animal protein food analogs. With this new funding, Navarra-based Cocuus aims to scale its business model and expand into other international markets, enabling the company to utilize its disruptive 3D bioprinting and robotics technologies.
Cocuus claims it can print cutlets, bacon, lamb ribs, and salmon at a rate of 8 kilograms per minute, without the need to slaughter a single animal, and has been selected as a finalist for the first edition of Spain Foodtech, a high-performance acceleration program focused on building solid technology-based Spanish startups in the agri-food value chain – supported by the National Center for Technology and Food Safety (CNTA) and ICEX Spain Export and Investment.
Cargill is increasingly diversifying into the alt protein sector, as shown by the company’s recent investment in another Spanish startup, Cubiq Foods, as part of a $6 million funding for the development of cultivated fat for plant-based alternatives. In addition to this, JBS SA, the largest meat processing company in the world, also recently completed the acquisition of Spanish cultivated meat startup, BioTech Foods.
“We are very proud to have attracted the interest of international investors with this round of financing. Thanks to this capital injection we will be able to bring our technology within reach of corporations that want to print proteins on an industrial scale,” said Patxi Larumbe, CEO and founder of Cocuus.